InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
LL-37 | Antiviral Effect of hBD-3 and LL-37 during Human Primary Keratinocyte Infecti... | 2022 | Viruses | Chessa C. et al. | DOI: 10.3390/v14071552 |
IFN-λ Reporter HEK 293 Cells | Antiviral Effect of hBD-3 and LL-37 during Human Primary Keratinocyte Infecti... | 2022 | Viruses | Chessa C. et al. | DOI: 10.3390/v14071552 |
Blasticidin | Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. | 2022 | Nucleic Acids Res. | Pollak A.J. et al. | DOI: 10.1093/nar/gkac618 |
Zeocin® | Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. | 2022 | Nucleic Acids Res. | Pollak A.J. et al. | DOI: 10.1093/nar/gkac618 |
Human TLR9 Reporter HEK293 Cells (NF-κB) | Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. | 2022 | Nucleic Acids Res. | Pollak A.J. et al. | DOI: 10.1093/nar/gkac618 |
Human TLR9 Reporter THP-1 Cells | Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. | 2022 | Nucleic Acids Res. | Pollak A.J. et al. | DOI: 10.1093/nar/gkac618 |
Normocin® - Antimicrobial Reagent | Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. | 2022 | Nucleic Acids Res. | Pollak A.J. et al. | DOI: 10.1093/nar/gkac618 |
Puromycin | Limiting Transactivator Amounts Contribute to Transgene Mosaicism in Tet-On A... | 2022 | ACS Synth Biol. | Duran A.G. et al. | DOI: 10.1021/acssynbio.2c00036 |
Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Robust coupling of angiogenesis and osteogenesis by VEGF-decorated matrices f... | 2022 | Acta Biomater. | Burger M.G. et al. | DOI: 10.1016/j.actbio.2022.07.014 |
ODN 1585 - TLR9 ligand | B cell-mediated regulatory mechanisms control tumor-promoting intestinal infl... | 2022 | Cell Rep. | Melcher C. et al. | DOI: 10.1016/j.celrep.2022.111051 |
LPS-EB VacciGrade™ | B cell-mediated regulatory mechanisms control tumor-promoting intestinal infl... | 2022 | Cell Rep. | Melcher C. et al. | DOI: 10.1016/j.celrep.2022.111051 |
LPS-EB (LPS from E. coli O111:B4) | Human alveolar macrophages do not rely on glucose metabolism upon activation ... | 2022 | Biochim Biophys Acta Mol Basis Dis. | Pereverzeva L. et al. | DOI: 10.1016/j.bbadis.2022.166488 |
Human ACE2 & TMPRSS2 expressing A549 Cells | Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting t... | 2022 | Int J Biol Sci. | Yan B. et al. | DOI: 10.7150/ijbs.73057 |
PlasmoTest™ - Mycoplasma Detection Kit | Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting t... | 2022 | Int J Biol Sci. | Yan B. et al. | DOI: 10.7150/ijbs.73057 |
IFN-α/β Reporter HEK 293 Cells | Apoptotic caspases suppress an MDA5-driven IFN response during productive rep... | 2022 | PNAS | Huang N. et al. | DOI: 10.1073/pnas.2200206119 |
IFN-λ Reporter HEK 293 Cells | Apoptotic caspases suppress an MDA5-driven IFN response during productive rep... | 2022 | PNAS | Huang N. et al. | DOI: 10.1073/pnas.2200206119 |
Anti-HLA Class I Control | Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants a... | 2022 | Nat Microbiol. | Fenwick C. et al. | DOI: 10.1038/s41564-022-01198-6 |
Zeocin® | A Nodal enhanced micropeptide NEMEP regulates glucose uptake during mesendode... | 2022 | Nat Commun. | Fu H. et al. | DOI: 10.1038/s41467-022-31762-x |
QUANTI-Blue™ | Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using d... | 2022 | Acta Biomater. | Yerneni S.S. et al. | DOI: 10.1016/j.actbio.2022.06.046 |
Normocin® - Antimicrobial Reagent | Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using d... | 2022 | Acta Biomater. | Yerneni S.S. et al. | DOI: 10.1016/j.actbio.2022.06.046 |